The World of Health & Medicine News

Smart sanitary pads use rapid test strips and AI app to reveal key health biomarkers

Smart sanitary pads use rapid test strips and AI app to reveal key health biomarkers

Researchers at ETH Zurich have developed the first technology that is able to recognize biomarkers in menstrual blood—directly in sanitary towels. MenstruAI promises a simple, non-invasive method for recording health data in everyday life.

The study is published in the journal Advanced Science.

The application is simple: wear a sanitary towel with the integrated, nonelectronic sensor, take a picture of the used towel with your smartphone and use the app to analyze it. MenstruAI is designed to enable users to check their health regularly and effortlessly. For the first time ever, a new technology from ETH Zurich is bringing a tracking tool to a place where hardly anyone would expect it: the sanitary towel.

Menstrual blood is a source of information

Over 1.8 billion individuals menstruate, yet menstrual blood hardly plays any role in medicine. “This reflects a systemic lack of interest in women’s health,” states Lucas Dosnon, first author and doctoral student in the group of Inge Herrmann, a professor at the University of Zurich, Balgrist University Hospital, Empa and accredited at the Department of Mechanical and Process Engineering at ETH Zurich.

“To date, menstrual blood has been regarded as waste. We are showing that it is a valuable source of information,” says Dosnon.

Menstrual blood contains hundreds of proteins, and for many of them there is a correlation with their concentration in venous blood. Numerous diseases, including tumors such as ovarian cancer or endometriosis, lead to the presence of certain proteins in blood, which can serve as biomarkers for disease detection.

The ETH researchers used three biomarkers as a starting point for MenstruAI. They currently record the C-reactive protein (CRP) as a general inflammation marker, the tumor marker CEA typically elevated in all kinds of cancers, and CA-125, a protein that can be elevated in endometriosis as well as in ovarian cancer.

Many more protein-based biomarkers are currently being investigated and will be added to the list to reflect many other aspects of an individual’s health.

spot_img

Explore more

spot_img

Bird Flu Is Now Killing Cats at a 90% Fatality Rate...

Bird Flu Is Now Killing Cats at a 90% Fatality Rate – Experts Warn It Could Jump to Humans Spring is here, birds are on...

Amgen drug cuts small cell lung cancer death risk by 40%

Amgen drug cuts small cell lung cancer death risk by 40% Amgen's (AMGN.O), opens new tab Imdelltra reduced the risk of death by 40% compared to chemotherapy...

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug...

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug partnership Bristol Myers Squibb (BMY.N), opens new tab will pay $1.5 billion upfront to partner with...

US FDA approves Moderna’s next-generation COVID vaccine for adults 65 or...

US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older The U.S. Food and Drug Administration has approved Moderna's (MRNA.O), opens new tab next-generation COVID-19...

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer...

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds Treating breast cancer patients with AstraZeneca's (AZN.L), opens new tab experimental pill camizestrant...

Dinosaurs could hold key to cancer discoveries, scientists say

Dinosaurs could hold key to cancer discoveries, scientists say Dinosaur fossils could hold the key to new cancer discoveries and influence future treatments for humans,...

Novartis’ Pluvicto shown to slow prostate cancer in earlier setting

Novartis' Pluvicto shown to slow prostate cancer in earlier setting  Novartis (NOVN.S), opens new tab said on Monday that its targeted radiotherapy Pluvicto was shown to slow...

US FDA launches AI tool to reduce time taken for scientific...

US FDA launches AI tool to reduce time taken for scientific reviews The U.S. Food and Drug Administration said on Monday that it had launched...